| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90033
Chemical and physical carcinogens leave footprints of their activities on DNA because of the patterns of base changes they induce. Additionally, the conversion of 5-methylcytosine to thymine in CpG sequences leads to a characteristic mutation which can be used to estimate the contribution of endogenous processes to human mutations. Knowledge of the pattern mutations found in genes commonly mutated in human cancer, such as the p53 tumor suppressor gene, allows for predictions to be made on the likelihood of an exogenous DNA-damaging agent being involved. Working from gene to carcinogen is likely to have a profound impact on our understanding of the origins of human cancer.
1 To whom requests for reprints should be addressed, at Institute of Animal Physiology and Genetics Research, Babraham, Cambridge CB2 4AT, United Kingdom.
Received 5/ 2/91. Accepted 5/16/91.
This article has been cited by other articles:
![]() |
I.A. Lea, M.A. Jackson, X. Li, S. Bailey, S.D. Peddada, and J.K. Dunnick Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns Carcinogenesis, September 1, 2007; 28(9): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diaz-Castillo and K. G. Golic Evolution of Gene Sequence in Response to Chromosomal Location Genetics, September 1, 2007; 177(1): 359 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, M. Hergenhahn, H. H. Schmeiser, G. N. Wogan, A. Hong, and M. Hollstein Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene PNAS, March 2, 2004; 101(9): 2963 - 2968. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueki, A. W. Hsing, Y.-T. Gao, B.-S. Wang, M.-C. Shen, J. Cheng, J. Deng, J. F. Fraumeni Jr., and A. Rashid Alterations of p16 and Prognosis in Biliary Tract Cancers from a Population-Based Study in China Clin. Cancer Res., March 1, 2004; 10(5): 1717 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Schroeder, K. Conway, Y. Li, K. Mistry, D. A. Bell, and J. A. Taylor p53 Mutations in Bladder Cancer: Evidence for Exogenous versus Endogenous Risk Factors Cancer Res., November 1, 2003; 63(21): 7530 - 7538. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shibata, J. Parsonnet, T. A. Longacre, M. I. Garcia, B. Puligandla, R.E. Davis, J. H. Vogelman, N. Orentreich, and L. A. Habel CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma Carcinogenesis, March 1, 2002; 23(3): 419 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Lazcano-Ponce, J. F. Miquel, N. Munoz, R. Herrero, C. Ferrecio, I. I. Wistuba, P. Alonso de Ruiz, G. Aristi Urista, and F. Nervi Epidemiology and Molecular Pathology of Gallbladder Cancer CA Cancer J Clin, November 1, 2001; 51(6): 349 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Ness and C. Cottreau Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer J Natl Cancer Inst, September 1, 1999; 91(17): 1459 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perz and J. G. Kuhn Review : p53 in the pathogenesis, diagnosis, and treatment of cancer Journal of Oncology Pharmacy Practice, June 1, 1998; 4(2): 75 - 102. [Abstract] [PDF] |
||||
![]() |
Y. Sun, G. Hegamyer, H. Kim, K. Sithanandam, H. Li, R. Watts, and N. H. Colburn Molecular Cloning of Mouse Tissue Inhibitor of Metalloproteinases-3 and Its Promoter J. Biol. Chem., August 18, 1995; 270(33): 19312 - 19319. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Harris and M. Hollstein Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327. [Full Text] |
||||
![]() |
B. Henderson, R. Ross, and M. Pike Toward the primary prevention of cancer Science, November 22, 1991; 254(5035): 1131 - 1138. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |